Logo

Bio-Rad, Beckman Coulter Extend Immunoassay Pact

May 31, 2007
NEW YORK (GenomeWeb News) — Bio-Rad Laboratories and Beckman Coulter have extended by eight years an alliance to develop and manufacture immunodiagnostic products that test for viral and infectious disease, Bio-Rad said today.
 
Under the new agreement, Bio-Rad said it will develop new blood-based immunoassays, including tests for hepatitis B and HIV, for Beckman’s UniCel and Access systems.
 
The company said some of these assays will test for chronic hepatitis or active infection, and that it plans to develop a next-generation HIV assay to detect the virus.
 
Financial terms of the extended agreement were not disclosed.

Breaking News
The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.